-
1
-
-
1942469957
-
Molecular targets in pituitary tumours
-
Heaney AP, Melmed S. Molecular targets in pituitary tumours. Nat. Rev. Cancer 4(4), 285-295 (2004).
-
(2004)
Nat. Rev. Cancer
, vol.4
, Issue.4
, pp. 285-295
-
-
Heaney, A.P.1
Melmed, S.2
-
2
-
-
34247180053
-
Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations
-
DOI 10.1073/pnas.0700004104
-
Georgitsi M, Raitila A, Karhu A et al. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations. Proc. Natl Acad. Sci. USA 104(10), 4101-4105 (2007). (Pubitemid 47181585)
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.10
, pp. 4101-4105
-
-
Georgitsi, M.1
Raitila, A.2
Karhu, A.3
Tuppurainen, K.4
Makinen, M.J.5
Vierimaa, O.6
Paschke, R.7
Saeger, W.8
Van Der Luijt, R.B.9
Sane, T.10
Robledo, M.11
De Menis, E.12
Weil, R.J.13
Wasik, A.14
Zielinski, G.15
Lucewicz, O.16
Lubinski, J.17
Launonen, V.18
Vahteristo, P.19
Aaltonen, L.A.20
more..
-
3
-
-
67849135776
-
Pituitary gland and β-catenin signalling: From ontogeny to oncogenesis
-
Gueorguiev M, Grossman AB. Pituitary gland and β-catenin signalling: from ontogeny to oncogenesis. Pituitary 12(3), 245-255 (2009).
-
(2009)
Pituitary
, vol.12
, Issue.3
, pp. 245-255
-
-
Gueorguiev, M.1
Grossman, A.B.2
-
4
-
-
29344440532
-
Classification and pathology of pituitary tumours
-
Kontogeorgos G. Classification and pathology of pituitary tumours. Endocrine 28(1), 27-35 (2005).
-
(2005)
Endocrine
, vol.28
, Issue.1
, pp. 27-35
-
-
Kontogeorgos, G.1
-
5
-
-
33750039991
-
Predictive markers of pituitary adenoma behavior
-
DOI 10.1159/000095526
-
Kontogeorgos G. Predictive markers of pituitary adenoma behavior. Neuroendocrinology 83(3-4), 179-188 (2006). • Important review presenting the importance of some classic predictive markers. (Pubitemid 44578870)
-
(2006)
Neuroendocrinology
, vol.83
, Issue.3-4
, pp. 179-188
-
-
Kontogeorgos, G.1
-
6
-
-
33748295612
-
Pathobiology of pituitary adenomas and carcinomas
-
Scheithauer BW, Gaffey TA, Lloyd RV et al. Pathobiology of pituitary adenomas and carcinomas. Neurosurgery 59(2), 341-353 (2006).
-
(2006)
Neurosurgery
, vol.59
, Issue.2
, pp. 341-353
-
-
Scheithauer, B.W.1
Gaffey, T.A.2
Lloyd, R.V.3
-
7
-
-
29544434613
-
The 2004 World Health Organization classification of pituitary tumours: What is new?
-
Al-Shraim M, Asa SL. The 2004 World Health Organization classification of pituitary tumours: what is new? Acta Neuropathol. 111(1), 1-7 (2006).
-
(2006)
Acta Neuropathol.
, vol.111
, Issue.1
, pp. 1-7
-
-
Al-Shraim, M.1
Asa, S.L.2
-
8
-
-
0036827156
-
Topoisomerase IIa expression in pituitary adenomas and carcinomas: Relationship to tumor behavior
-
DOI 10.1097/01.MP.0000036342.73003.55
-
Vidal S, Kovacs K, Horvath E et al. Topoisomerase IIa expression in pituitary adenomas and carcinomas: relationship to tumour behavior. Mod. Pathol. 15(11), 1205-1212 (2002). (Pubitemid 35435139)
-
(2002)
Modern Pathology
, vol.15
, Issue.11
, pp. 1205-1212
-
-
Vidal, S.1
Kovacs, K.2
Horvath, E.3
Rotondo, F.4
Kuroki, T.5
Lloyd, R.V.6
Scheithauer, B.W.7
-
9
-
-
0038521395
-
Cyclooxygenase-2 expression in human pituitary tumors
-
DOI 10.1002/cncr.11387
-
Vidal S, Kovacs K, Bell D, Horvath E, Scheithauer BW, Lloyd RV. Cyclooxygenase-2 expression in human pituitary tumours. Cancer 97(11), 2814-2821 (2003). (Pubitemid 36605150)
-
(2003)
Cancer
, vol.97
, Issue.11
, pp. 2814-2821
-
-
Vidal, S.1
Kovacs, K.2
Bell, D.3
Horvath, E.4
Scheithauer, B.W.5
Lloyd, R.V.6
-
10
-
-
0037789551
-
Expression of hypoxia-inducible factor-1α (HIF-1α) in pituitary tumours
-
Vidal S, Horvath E, Kovacs K, Kuroki T, Lloyd RV, Scheithauer BW. Expression of hypoxia-inducible factor-1α (HIF-1α) in pituitary tumours. Histol. Histopathol. 18(3), 679-686 (2003). (Pubitemid 36773211)
-
(2003)
Histology and Histopathology
, vol.18
, Issue.3
, pp. 679-686
-
-
Vidal, S.1
Horvath, E.2
Kovacs, K.3
Kuroki, T.4
Lloyd, R.V.5
Scheithauer, B.W.6
-
11
-
-
0038427460
-
Microvascular Structural Entropy: A Novel Approach to Assess Angiogenesis in Pituitary Tumors
-
DOI 10.1385/EP:14:3:239
-
Vidal S, Horvath E, Kovacs K, Lloyd RV, Scheithauer BW. Microvascular structural entropy: a novel approach to assess angiogenesis in pituitary tumours. Endocr. Pathol. 14(3), 239-247 (2003). (Pubitemid 37346705)
-
(2003)
Endocrine Pathology
, vol.14
, Issue.3
, pp. 239-247
-
-
Vidal, S.1
Horvath, E.2
Kovacs, K.3
Lloyd, R.V.4
Scheithauer, B.W.5
-
12
-
-
66449089619
-
Epidermal growth factor receptor pathway substrate 8 (Eps8) is over expressed in human pituitary tumours: Role in proliferation and survival
-
Xu M, Shorts-Cary L, Knox AJ, Kleinsmidt-Demasters B, Lillehei K, Wierman ME. Epidermal growth factor receptor pathway substrate 8 (Eps8) is over expressed in human pituitary tumours: role in proliferation and survival. Endocrinology 150(5), 2064-2071 (2009).
-
(2009)
Endocrinology
, vol.150
, Issue.5
, pp. 2064-2071
-
-
Xu, M.1
Shorts-Cary, L.2
Knox, A.J.3
Kleinsmidt-Demasters, B.4
Lillehei, K.5
Wierman, M.E.6
-
13
-
-
29344469088
-
-
Karger Publishers, Basel, Switzerland Summarizes the current knowledge on molecular pituitary pathology
-
Kontogeorgos G, Kovács K. Molecular Pathology of the Pituitary. Karger Publishers, Basel, Switzerland (2004). •• Summarizes the current knowledge on molecular pituitary pathology.
-
(2004)
Molecular Pathology of the Pituitary
-
-
Kontogeorgos, G.1
Kovács, K.2
-
14
-
-
33750901834
-
Pituitary tumour pathogenesis
-
Discusses candidate factors in pituitary tumorigenesis, including dysregulated signaling pathways
-
Heaney AP. Pituitary tumour pathogenesis. Br. Med. Bull. 75-76, 81-97 (2005). • Discusses candidate factors in pituitary tumorigenesis, including dysregulated signaling pathways.
-
(2005)
Br. Med. Bull.
, vol.75-76
, pp. 81-97
-
-
Heaney, A.P.1
-
15
-
-
67849126387
-
The molecular biology of pituitary tumours: A personal perspective
-
Addresses overexpression of the pituitary tumor transforming gene (PTTG), Akt and MAPK leading to cell cycle dysregulation
-
Grossman AB. The molecular biology of pituitary tumours: a personal perspective. Pituitary 12(3), 265-270 (2009). •• Addresses overexpression of the pituitary tumor transforming gene (PTTG), Akt and MAPK leading to cell cycle dysregulation.
-
(2009)
Pituitary
, vol.12
, Issue.3
, pp. 265-270
-
-
Grossman, A.B.1
-
16
-
-
0141864375
-
Genetics of pituitary tumors: Focus on G-protein mutations
-
Lania A, Mantovani G, Spada A. Genetics of pituitary tumours: focus on G-protein mutations. Exp. Biol. Med. (Maywood) 228(9), 1004-1017 (2003). (Pubitemid 37222168)
-
(2003)
Experimental Biology and Medicine
, vol.228
, Issue.9
, pp. 1004-1017
-
-
Lania, A.1
Mantovani, G.2
Spada, A.3
-
17
-
-
64149113840
-
Cell cycle control of pituitary development and disease
-
Quereda V, Malumbres M. Cell cycle control of pituitary development and disease. J. Mol. Endocrinol. 42(2), 75-86 (2009).
-
(2009)
J. Mol. Endocrinol.
, vol.42
, Issue.2
, pp. 75-86
-
-
Quereda, V.1
Malumbres, M.2
-
18
-
-
53849096004
-
Pituitary tumor-transforming gene in endocrine and other neoplasms: A review and update
-
Points out the role of PTTG in pituitary tumor development, emphasizing the correlation between its overexpression and angiogenesis and recurrence
-
Salehi F, Kovacs K, Scheithauer BW, Lloyd RV, Cusimano M. Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update. Endocr. Relat. Cancer 15(3), 721-743 (2008). •• Points out the role of PTTG in pituitary tumor development, emphasizing the correlation between its overexpression and angiogenesis and recurrence.
-
(2008)
Endocr. Relat. Cancer
, vol.15
, Issue.3
, pp. 721-743
-
-
Salehi, F.1
Kovacs, K.2
Scheithauer, B.W.3
Lloyd, R.V.4
Cusimano, M.5
-
19
-
-
66249127952
-
Heregulin regulates prolactinoma gene expression
-
Vlotides G, Cooper O, Chen YH, Ren SG, Greenman Y, Melmed S. Heregulin regulates prolactinoma gene expression. Cancer Res. 69(10), 4209-4216 (2009).
-
(2009)
Cancer Res.
, vol.69
, Issue.10
, pp. 4209-4216
-
-
Vlotides, G.1
Cooper, O.2
Chen, Y.H.3
Ren, S.G.4
Greenman, Y.5
Melmed, S.6
-
20
-
-
58049191405
-
Mechanisms of pituitary tumorigenesis
-
Acunzo J, Saveanu A, Gerard C, Enjalbert A, Barlier A. Mechanisms of pituitary tumorigenesis. Presse Med. 38(1), 76-83 (2009).
-
(2009)
Presse Med.
, vol.38
, Issue.1
, pp. 76-83
-
-
Acunzo, J.1
Saveanu, A.2
Gerard, C.3
Enjalbert, A.4
Barlier, A.5
-
21
-
-
34248231793
-
Hormonal signalling and pituitary adenomas
-
Spada A, Lania A, Mantovani G. Hormonal signalling and pituitary adenomas. Neuroendocrinology 85(2), 101-109 (2007).
-
(2007)
Neuroendocrinology
, vol.85
, Issue.2
, pp. 101-109
-
-
Spada, A.1
Lania, A.2
Mantovani, G.3
-
22
-
-
48749133420
-
Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK)
-
Yoshida D, Nomura R, Teramoto A. Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK). J. Neurooncol. 89(2), 141-150 (2008).
-
(2008)
J. Neurooncol.
, vol.89
, Issue.2
, pp. 141-150
-
-
Yoshida, D.1
Nomura, R.2
Teramoto, A.3
-
23
-
-
34249668278
-
Pituitary tumor-transforming gene: Physiology and implications for tumorigenesis
-
Addresses correlation of PTTG expression with pituitary gland plasticity and tumor formation potential
-
Vlotides G, Eigler T, Melmed S. Pituitary tumor-transforming gene: physiology and implications for tumorigenesis. Endocr. Rev. 28(2), 165-186 (2007). • Addresses correlation of PTTG expression with pituitary gland plasticity and tumor formation potential.
-
(2007)
Endocr. Rev.
, vol.28
, Issue.2
, pp. 165-186
-
-
Vlotides, G.1
Eigler, T.2
Melmed, S.3
-
24
-
-
56849103886
-
Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsa protein mutation
-
Sakai N, Kim K, Sanno N, Yoshida D, Teramoto A, Shibasaki T. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsa protein mutation. Neurol. Med. Chir. 48(11), 481-487 (2008).
-
(2008)
Neurol. Med. Chir.
, vol.48
, Issue.11
, pp. 481-487
-
-
Sakai, N.1
Kim, K.2
Sanno, N.3
Yoshida, D.4
Teramoto, A.5
Shibasaki, T.6
-
25
-
-
34547635253
-
A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors
-
DOI 10.1158/0008-5472.CAN-07-0219
-
Asa SL, Digiovanni R, Jiang J et al. A growth hormone receptor mutation impairs growth hormone autofeedback signalling in pituitary tumours. Cancer Res. 67(15), 7505-7511 (2007). (Pubitemid 47206580)
-
(2007)
Cancer Research
, vol.67
, Issue.15
, pp. 7505-7511
-
-
Asa, S.L.1
Digiovanni, R.2
Jiang, J.3
Ward, M.L.4
Loesch, K.5
Yamada, S.6
Sano, T.7
Yoshimoto, K.8
Frank, S.J.9
Ezzat, S.10
-
26
-
-
32944477371
-
Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression
-
DOI 10.1158/0008-5472.CAN-05-1189
-
Theodoropoulou M, Zhang J, Laupheimer S et al. Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signalling and inducing Zac1 expression. Cancer Res. 66(3), 1576-1582 (2006). (Pubitemid 43259940)
-
(2006)
Cancer Research
, vol.66
, Issue.3
, pp. 1576-1582
-
-
Theodoropoulou, M.1
Zhang, J.2
Laupheimer, S.3
Paez-Pereda, M.4
Erneux, C.5
Florio, T.6
Pagotto, U.7
Stalla, G.K.8
-
27
-
-
33747635920
-
Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours
-
DOI 10.1530/eje.1.02213
-
Hubina E, Nanzer AM, Hanson MR et al. Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours. Eur. J. Endocrinol. 155(2), 371-379 (2006). •• Suggests that the antiproliferative effect of somatostatin could be explained by downregulation of pERK and upregulation of p27. (Pubitemid 44269455)
-
(2006)
European Journal of Endocrinology
, vol.155
, Issue.2
, pp. 371-379
-
-
Hubina, E.1
Nanzer, A.M.2
Hanson, M.R.3
Ciccarelli, E.4
Losa, M.5
Gaia, D.6
Papotti, M.7
Terreni, M.R.8
Khalaf, S.9
Jordan, S.10
Czirjak, S.11
Hanzely, Z.12
Nagy, G.M.13
Goth, M.I.14
Grossman, A.B.15
Korbonits, M.16
-
28
-
-
67649304857
-
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology
-
Ferone D, Gatto F, Arvigo M et al. The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology. J. Mol. Endocrinol. 42(5), 361-370 (2009).
-
(2009)
J. Mol. Endocrinol.
, vol.42
, Issue.5
, pp. 361-370
-
-
Ferone, D.1
Gatto, F.2
Arvigo, M.3
-
29
-
-
58049165874
-
Signalling by G-protein-coupled receptor (GPCR): Studies on the GnRH receptor
-
Naor Z. Signalling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor. Front. Neuroendocrinol. 30(1), 10-29 (2009).
-
(2009)
Front. Neuroendocrinol.
, vol.30
, Issue.1
, pp. 10-29
-
-
Naor, Z.1
-
30
-
-
33745186237
-
Activation of Mitogen-activated protein kinase (MAPK) by GnRH is cell-context dependent
-
DOI 10.1016/j.mce.2006.03.035, PII S0303720706001262
-
Dobkin-Bekman M, Naidich M, Pawson AJ, Millar RP, Seger R, Naor Z. Activation of mitogen-activated protein kinase (MAPK) by GnRH is cell-context dependent. Mol. Cell. Endocrinol. 252(1-2), 184-190 (2006). (Pubitemid 43914095)
-
(2006)
Molecular and Cellular Endocrinology
, vol.252
, Issue.1-2
, pp. 184-190
-
-
Dobkin-Bekman, M.1
Naidich, M.2
Pawson, A.J.3
Millar, R.P.4
Seger, R.5
Naor, Z.6
-
31
-
-
4143145476
-
2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways
-
DOI 10.1158/0008-5472.CAN-04-1156
-
Kraus S, Levy G, Hanoch T, Naor Z, Seger R. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extra cellular signal-regulated kinase pathways. Cancer Res. 64(16), 5736-5744 (2004). (Pubitemid 39095572)
-
(2004)
Cancer Research
, vol.64
, Issue.16
, pp. 5736-5744
-
-
Kraus, S.1
Levy, G.2
Hanoch, T.3
Naor, Z.4
Seger, R.5
-
32
-
-
33644992893
-
Gonadotropin-releasing hormone in apoptosis of prostate cancer cells
-
Kraus S, Naor Z, Seger R. Gonadotropin-releasing hormone in apoptosis of prostate cancer cells. Cancer Lett. 234(2), 109-123 (2006).
-
(2006)
Cancer Lett.
, vol.234
, Issue.2
, pp. 109-123
-
-
Kraus, S.1
Naor, Z.2
Seger, R.3
-
33
-
-
5644247440
-
i-coupling state of the type I GnRH receptor
-
DOI 10.1158/0008-5472.CAN-04-1360
-
Maudsley S, Davidson L, Pawson AJ, Chan R, Lopez de Maturana R, Millar RP. Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signalling in peripheral reproductive tumor cells by activating a Gαi-coupling state of the type I GnRH receptor. Cancer Res. 64(20), 7533-7544 (2004). (Pubitemid 39372098)
-
(2004)
Cancer Research
, vol.64
, Issue.20
, pp. 7533-7544
-
-
Maudsley, S.1
Davidson, L.2
Pawson, A.J.3
Chan, R.4
Lopez De Maturana, R.5
Millar, R.P.6
-
34
-
-
15944401007
-
Extracellular signal-regulated protein kinase, but not c-Jun N-terminal kinase, is activated by type II gonadotropin-releasing hormone involved in the inhibition of ovarian cancer cell proliferation
-
DOI 10.1210/jc.2004-1636
-
Kim KY, Choi KC, Park SH, Auersperg N, Leung PC. Extra cellular signal-regulated protein kinase, but not c-Jun N-terminal kinase, is activated by type II gonadotropin-releasing hormone involved in the inhibition of ovarian cancer cell proliferation. J. Clin. Endocrinol. Metab. 90(3), 1670-1677 (2005). (Pubitemid 40464036)
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.3
, pp. 1670-1677
-
-
Kim, K.-Y.1
Choi, K.-C.2
Park, S.-H.3
Auersperg, N.4
Leung, P.C.K.5
-
36
-
-
27244451319
-
Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas
-
DOI 10.2152/jmi.52.151
-
Liu W, Matsumoto Y, Okada M et al. Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas. J. Med. Invest. 52(3-4), 151-158 (2005). (Pubitemid 41602589)
-
(2005)
Journal of Medical Investigation
, vol.52
, Issue.3-4
, pp. 151-158
-
-
Liu, W.1
Matsumoto, Y.2
Okada, M.3
Miyake, K.4
Kunishio, K.5
Kawai, N.6
Tamiya, T.7
Nagao, S.8
-
37
-
-
38649089803
-
Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas
-
DOI 10.1007/s11102-007-0066-2
-
Gong J, Zhao Y, Abdel-Fattah R et al. Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas. Pituitary 11(1), 37-48 (2008). (Pubitemid 351168083)
-
(2008)
Pituitary
, vol.11
, Issue.1
, pp. 37-48
-
-
Gong, J.1
Zhao, Y.2
Abdel-Fattah, R.3
Amos, S.4
Xiao, A.5
Lopes, M.B.S.6
Hussaini, I.S.7
Laws, E.R.8
-
38
-
-
33847037173
-
Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line
-
DOI 10.2353/ajpath.2007.060736
-
Hussaini IM, Trotter C, Zhao Y, et al. Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am. J. Pathol. 170(1), 356-365 (2007). (Pubitemid 47339213)
-
(2007)
American Journal of Pathology
, vol.170
, Issue.1
, pp. 356-365
-
-
Hussaini, I.M.1
Trotter, C.2
Zhao, Y.3
Abdel-Fattah, R.4
Amos, S.5
Xiao, A.6
Agi, C.U.7
Redpath, G.T.8
Fang, Z.9
Leung, G.K.K.10
Lopes, M.B.S.11
Laws Jr., E.R.12
-
39
-
-
0036852624
-
Functional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas
-
Heaney AP, Fernando M, Yong WH, Melmed S. Functional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas. Nat. Med. 8(11), 1281-1287 (2002).
-
(2002)
Nat. Med.
, vol.8
, Issue.11
, pp. 1281-1287
-
-
Heaney, A.P.1
Fernando, M.2
Yong, W.H.3
Melmed, S.4
-
40
-
-
0034776771
-
Retinoic acid prevents experimental Cushing syndrome
-
DOI 10.1172/JCI200111098
-
Paez-Pereda M, Kovalovsky D, Hopfner U et al. Retinoic acid prevents experimental Cushing syndrome. J. Clin. Invest. 108(8), 1123-1131 (2001). (Pubitemid 32995370)
-
(2001)
Journal of Clinical Investigation
, vol.108
, Issue.8
, pp. 1123-1131
-
-
Paez-Pereda, M.1
Kovalovsky, D.2
Hopfner, U.3
Theodoropoulou, M.4
Pagotto, U.5
Uhl, E.6
Losa, M.7
Stalla, J.8
Grubler, Y.9
Missale, C.10
Arzt, E.11
Stalla, G.K.12
-
41
-
-
0036153636
-
Functional role of estrogen in pituitary tumor pathogenesis
-
DOI 10.1172/JCI200214264
-
Heaney AP, Fernando M, Melmed S. Functional role of estrogen in pituitary tumor pathogenesis. J. Clin. Invest. 109(2), 277-283 (2002). (Pubitemid 34083748)
-
(2002)
Journal of Clinical Investigation
, vol.109
, Issue.2
, pp. 277-283
-
-
Heaney, A.P.1
Fernando, M.2
Melmed, S.3
-
42
-
-
70349248419
-
Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues
-
Hazell G, Yao S, Roper J, Prossnitz E, O'Carroll AM, Lolait S. Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues. J. Endocrinol. 202(2), 223-236 (2009).
-
(2009)
J. Endocrinol.
, vol.202
, Issue.2
, pp. 223-236
-
-
Hazell, G.1
Yao, S.2
Roper, J.3
Prossnitz, E.4
O'Carroll, A.M.5
Lolait, S.6
-
43
-
-
36348947509
-
Expression of G protein-coupled receptor-30, a G protein-coupled membrane estrogen receptor, in oxytocin neurons of the rat paraventricular and supraoptic nuclei
-
DOI 10.1210/en.2007-0436
-
Sakamoto H, Matsuda K, Hosokawa K et al. Expression of G protein-coupled receptor-30, a G protein-coupled membrane estrogen receptor, in oxytocin neurons of the rat paraventricular and supraoptic nuclei. Endocrinology 148(12), 5842-5850 (2007). (Pubitemid 350146173)
-
(2007)
Endocrinology
, vol.148
, Issue.12
, pp. 5842-5850
-
-
Sakamoto, H.1
Matsuda, K.-I.2
Hosokawa, K.3
Nishi, M.4
Morris, J.F.5
Prossnitz, E.R.6
Kawata, M.7
-
44
-
-
14044250986
-
Differential role of progesterone receptor isoforms in the transcriptional regulation of human gonadotropin-releasing hormone I (GnRH I) receptor, GnRH I, and GnRH II
-
An BS, Choi JH, Choi KC, Leung PC. Differential role of progesterone receptor isoforms in the transcriptional regulation of human gonadotropin-releasing hormone I (GnRH I) receptor, GnRH I, and GnRH II. J. Clin. Endocrinol. Metab. 90(2), 1106-1113 (2005).
-
(2005)
J. Clin. Endocrinol. Metab.
, vol.90
, Issue.2
, pp. 1106-1113
-
-
An, B.S.1
Choi, J.H.2
Choi, K.C.3
Leung, P.C.4
-
45
-
-
42149150383
-
Levonorgestrel antagonism on estrogen-induced pituitary tumours is mediated by progesterone receptors
-
Rey-Roldan EB, Grillo CA, Pietranera L, Libertun C, Nicola AF, Piroli GG. Levonorgestrel antagonism on estrogen-induced pituitary tumours is mediated by progesterone receptors. Horm. Metab. Res. 40(4), 245-250 (2008).
-
(2008)
Horm. Metab. Res.
, vol.40
, Issue.4
, pp. 245-250
-
-
Rey-Roldan, E.B.1
Grillo, C.A.2
Pietranera, L.3
Libertun, C.4
Nicola, A.F.5
Piroli, G.G.6
-
46
-
-
0037297587
-
The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas
-
Hunter JA, Skelly RH, Aylwin SJ et al. The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas. Eur. J. Endocrinol. 148(2), 203-211 (2003).
-
(2003)
Eur. J. Endocrinol.
, vol.148
, Issue.2
, pp. 203-211
-
-
Hunter, J.A.1
Skelly, R.H.2
Aylwin, S.J.3
-
47
-
-
34547821490
-
Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis
-
Boikos SA, Stratakis CA. Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis. Hum. Mol. Genet. 16(Spec. No. 1), R80-R87 (2007).
-
(2007)
Hum. Mol. Genet.
, vol.16
, Issue.SPEC. NO. 1
-
-
Boikos, S.A.1
Stratakis, C.A.2
-
48
-
-
0035906989
-
Securin is required for chromosomal stability in human cells
-
DOI 10.1016/S0092-8674(01)00340-3
-
Jallepalli PV, Waizenegger IC, Bunz F et al. Securin is required for chromosomal stability in human cells. Cell 105(4), 445-457 (2001). (Pubitemid 32520851)
-
(2001)
Cell
, vol.105
, Issue.4
, pp. 445-457
-
-
Jallepalli, P.V.1
Waizenegger, I.C.2
Bunz, F.3
Langer, S.4
Speicher, M.R.5
Peters, J.-M.6
Kinzler, K.W.7
Vogelstein, B.8
Lengauer, C.9
-
49
-
-
0034613183
-
Activation of mitogen-activated protein kinase cascade regulates pituitary tumor-transforming gene transactivation function
-
Pei L. Activation of mitogen-activated protein kinase cascade regulates pituitary tumor-transforming gene transactivation function. J. Biol. Chem. 275(40), 31191-31198 (2000). (Pubitemid 30757781)
-
(2000)
Journal of Biological Chemistry
, vol.275
, Issue.40
, pp. 31191-31198
-
-
Pei, L.1
-
50
-
-
0035869213
-
Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase
-
Romero F, Multon MC, Ramos-Morales F et al. Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase. Nucleic Acids Res. 29(6), 1300-1307 (2001). (Pubitemid 32229457)
-
(2001)
Nucleic Acids Research
, vol.29
, Issue.6
, pp. 1300-1307
-
-
Romero, F.1
Multon, M.-C.2
Ramos-Morales, F.3
Dominguez, A.4
Bernal, J.A.5
Pintor-Toro, J.A.6
Tortolero, M.7
-
51
-
-
35948972215
-
A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors
-
DOI 10.1677/ERC-07-0062
-
Wierinckx A, Auger C, Devauchelle P et al. A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumours. Endocr. Relat. Cancer 14(3), 887-900 (2007). (Pubitemid 350074076)
-
(2007)
Endocrine-Related Cancer
, vol.14
, Issue.3
, pp. 887-900
-
-
Wierinckx, A.1
Auger, C.2
Devauchelle, P.3
Reynaud, A.4
Chevallier, P.5
Jan, M.6
Perrin, G.7
Fevre-Montange, M.8
Rey, C.9
Figarella-Branger, D.10
Raverot, G.11
Belin, M.-F.12
Lachuer, J.13
Trouillas, J.14
-
52
-
-
17444428865
-
Regulation of the pituitary tumor transforming gene by insulin-like-growth factor-I and insulin differs between malignant and non-neoplastic astrocytes
-
DOI 10.1016/j.bbrc.2005.03.124
-
Chamaon K, Kirches E, Kanakis D, Braeuninger S, Dietzmann K, Mawrin C. Regulation of the pituitary tumor transforming gene by insulin-like-growth factor-I and insulin differs between malignant and non-neoplastic astrocytes. Biochem. Biophys. Res. Commun. 331(1), 86-92 (2005). (Pubitemid 40545146)
-
(2005)
Biochemical and Biophysical Research Communications
, vol.331
, Issue.1
, pp. 86-92
-
-
Chamaon, K.1
Kirches, E.2
Kanakis, D.3
Braeuninger, S.4
Dietzmann, K.5
Mawrin, C.6
-
53
-
-
0036788641
-
Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis
-
Bernal JA, Luna R, Espina A et al. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat. Genet. 32(2), 306-311 (2002).
-
(2002)
Nat. Genet.
, vol.32
, Issue.2
, pp. 306-311
-
-
Bernal, J.A.1
Luna, R.2
Espina, A.3
-
54
-
-
13644269946
-
PTTG/securin activates expression of p53 and modulates its function
-
DOI 10.1186/1476-4598-3-18
-
Hamid T, Kakar SS. PTTG/securin activates expression of p53 and modulates its function. Mol. Cancer 3, 18 (2004). (Pubitemid 40230554)
-
(2004)
Molecular Cancer
, vol.3
, pp. 18
-
-
Hamid, T.1
Kakar, S.S.2
-
55
-
-
35948990011
-
Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth
-
DOI 10.1158/0008-5472.CAN-07-0974
-
Chesnokova V, Zonis S, Rubinek T et al. Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. Cancer Res. 67(21), 10564-10572 (2007). (Pubitemid 350070833)
-
(2007)
Cancer Research
, vol.67
, Issue.21
, pp. 10564-10572
-
-
Chesnokova, V.1
Zonis, S.2
Rubinek, T.3
Yu, R.4
Ben-Shlomo, A.5
Kovacs, K.6
Wawrowsky, K.7
Melmed, S.8
-
56
-
-
18544383958
-
Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumours
-
McCabe CJ, Boelaert K, Tannahill LA et al. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumours. J. Clin. Endocrinol. Metab. 87(9), 4238-4244 (2002).
-
(2002)
J. Clin. Endocrinol. Metab.
, vol.87
, Issue.9
, pp. 4238-4244
-
-
McCabe, C.J.1
Boelaert, K.2
Tannahill, L.A.3
-
57
-
-
33845701415
-
PTTG overexpression is correlated with angiogenesis in human pituitary adenomas
-
DOI 10.1385/EP:17:2:143, PII EP172143
-
Minematsu T, Suzuki M, Sanno N, Takekoshi S, Teramoto A, Osamura RY. PTTG overexpression is correlated with angiogenesis in human pituitary adenomas. Endocr. Pathol. 17(2), 143-532006 (2002). (Pubitemid 44965903)
-
(2006)
Endocrine Pathology
, vol.17
, Issue.2
, pp. 143-153
-
-
Minematsu, T.1
Suzuki, M.2
Sanno, N.3
Takekoshi, S.4
Teramoto, A.5
Osamura, R.Y.6
-
58
-
-
33748740748
-
Pituitary tumor transforming gene overexpression facilitates pituitary tumor development
-
DOI 10.1210/en.2006-0544
-
Donangelo I, Gutman S, Horvath E et al. Pituitary tumor transforming gene overexpression facilitates pituitary tumor development. Endocrinology 147(10), 4781-4791 (2006). (Pubitemid 44402185)
-
(2006)
Endocrinology
, vol.147
, Issue.10
, pp. 4781-4791
-
-
Donangelo, I.1
Gutman, S.2
Horvath, E.3
Kovacs, K.4
Wawrowsky, K.5
Mount, M.6
Melmed, S.7
-
60
-
-
33748807072
-
Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: A clinical and immunohistochemical study
-
DOI 10.1111/j.1365-2265.2006.02630.x
-
Filippella M, Galland F, Kujas M et al. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study. Clin. Endocrinol. (Oxf.) 65(4), 536-543 (2006). (Pubitemid 44414280)
-
(2006)
Clinical Endocrinology
, vol.65
, Issue.4
, pp. 536-543
-
-
Filippella, M.1
Galland, F.2
Kujas, M.3
Young, J.4
Faggiano, A.5
Lombardi, G.6
Colao, A.7
Meduri, G.8
Chanson, P.9
-
61
-
-
0037322597
-
Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: Relationships to clinical tumour behaviour
-
DOI 10.1046/j.1365-2265.2003.01598.x
-
McCabe CJ, Khaira JS, Boelaert K et al. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour. Clin. Endocrinol. (Oxf.) 58(2), 141-150 (2003). (Pubitemid 36194267)
-
(2003)
Clinical Endocrinology
, vol.58
, Issue.2
, pp. 141-150
-
-
McCabe, C.J.1
Khaira, J.S.2
Boelaert, K.3
Heaney, A.P.4
Tannahill, L.A.5
Hussain, S.6
Mitchell, R.7
Olliff, J.8
Sheppard, M.C.9
Franklyn, J.A.10
Gittoes, N.J.L.11
-
62
-
-
21244459233
-
Expression and functional analysis of pituitary tumor transforming gene-1 [corrected] in uterine leiomyomas
-
Tsai SJ, Lin SJ, Cheng YM, Chen HM, Wing LY. Expression and functional analysis of pituitary tumor transforming gene-1 [corrected] in uterine leiomyomas. J. Clin. Endocrinol. Metab. 90(6), 3715-3723 (2005).
-
(2005)
J. Clin. Endocrinol. Metab.
, vol.90
, Issue.6
, pp. 3715-3723
-
-
Tsai, S.J.1
Lin, S.J.2
Cheng, Y.M.3
Chen, H.M.4
Wing, L.Y.5
-
63
-
-
0037322598
-
Promoter mutations are no major cause of PTTG overexpression in pituitary adenomas
-
DOI 10.1046/j.1365-2265.2003.01683.x
-
Kanakis D, Kirches E, Mawrin C, Dietzmann K. Promoter mutations are no major cause of PTTG overexpression in pituitary adenomas. Clin. Endocrinol. (Oxf.) 58(2), 151-155 (2003). (Pubitemid 36194268)
-
(2003)
Clinical Endocrinology
, vol.58
, Issue.2
, pp. 151-155
-
-
Kanakis, D.1
Kirches, E.2
Mawrin, C.3
Dietzmann, K.4
-
64
-
-
0442295074
-
Expression of novel neurotrophin-1/B-cell stimulating factor-3 (NNT-1/BSF-3) in murine pituitary folliculostellate TtT/GF cells: Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-induced stimulation of NNT-1/BSF-3 is mediated by protein kinase A, protein kinase C, and extra cellular-signal-regulated kinase1/2 pathways
-
Vlotides G, Zitzmann K, Hengge S, Engelhardt D, Stalla GK, Auernhammer CJ. Expression of novel neurotrophin-1/B-cell stimulating factor-3 (NNT-1/BSF-3) in murine pituitary folliculostellate TtT/GF cells: pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-induced stimulation of NNT-1/BSF-3 is mediated by protein kinase A, protein kinase C, and extra cellular-signal-regulated kinase1/2 pathways. Endocrinology 145(2), 716-727 (2004).
-
(2004)
Endocrinology
, vol.145
, Issue.2
, pp. 716-727
-
-
Vlotides, G.1
Zitzmann, K.2
Hengge, S.3
Engelhardt, D.4
Stalla, G.K.5
Auernhammer, C.J.6
-
65
-
-
33751536478
-
Mechanisms for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT/GF cells
-
DOI 10.1210/me.2006-0280
-
Vlotides G, Cruz-Soto M, Rubinek T, Eigler T, Auernhammer CJ, Melmed S. Mechanisms for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT/GF cells. Mol. Endocrinol. 20(12), 3321-3335 (2006). (Pubitemid 44834329)
-
(2006)
Molecular Endocrinology
, vol.20
, Issue.12
, pp. 3321-3335
-
-
Vlotides, G.1
Cruz-Soto, M.2
Rubinek, T.3
Eigler, T.4
Auernhammer, C.J.5
Melmed, S.6
-
66
-
-
38949183695
-
Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy
-
Friday BB, Adjei AA. Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy. Clin. Cancer Res. 14(2), 342-346 (2008).
-
(2008)
Clin. Cancer Res.
, vol.14
, Issue.2
, pp. 342-346
-
-
Friday, B.B.1
Adjei, A.A.2
-
67
-
-
42049083552
-
Low levels of raf kinase inhibitory protein in growth hormone-secreting pituitary adenomas correlate with poor response to octreotide treatment
-
Fougner SL, Bollerslev J, Latif F et al. Low levels of raf kinase inhibitory protein in growth hormone-secreting pituitary adenomas correlate with poor response to octreotide treatment. J. Clin. Endocrinol. Metab. 93(4), 1211-1216 (2008).
-
(2008)
J. Clin. Endocrinol. Metab.
, vol.93
, Issue.4
, pp. 1211-1216
-
-
Fougner, S.L.1
Bollerslev, J.2
Latif, F.3
-
68
-
-
2942597289
-
Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway
-
DOI 10.1530/eje.0.1510233
-
Nanzer AM, Khalaf S, Mozid AM et al. Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway. Eur. J. Endocrinol. 151(2), 233-240 (2004). (Pubitemid 39207019)
-
(2004)
European Journal of Endocrinology
, vol.151
, Issue.2
, pp. 233-240
-
-
Nanzer, A.M.1
Khalaf, S.2
Mozid, A.M.3
Fowkes, R.C.4
Patel, M.V.5
Burrin, J.M.6
Grossman, A.B.7
Korbonits, M.8
-
69
-
-
0142024971
-
Fibroblast growth factors regulate prolactin transcription via an atypical Rac-dependent signalling pathway
-
Jackson TA, Koterwas DM, Morgan MA, Bradford AP. Fibroblast growth factors regulate prolactin transcription via an atypical Rac-dependent signalling pathway. Mol. Endocrinol. 17(10), 1921-1930 (2003).
-
(2003)
Mol. Endocrinol.
, vol.17
, Issue.10
, pp. 1921-1930
-
-
Jackson, T.A.1
Koterwas, D.M.2
Morgan, M.A.3
Bradford, A.P.4
-
70
-
-
58149176620
-
Protein kinase a serves as a primary pathway in activation of Nur77 expression by gonadotropin-releasing hormone in the LβT2 mouse pituitary gonadotroph tumor cell line
-
Hamid T, Malik MT, Millar RP, Kakar SS. Protein kinase A serves as a primary pathway in activation of Nur77 expression by gonadotropin-releasing hormone in the LβT2 mouse pituitary gonadotroph tumor cell line. Int. J. Oncol. 33(5), 1055-1064 (2008).
-
(2008)
Int. J. Oncol.
, vol.33
, Issue.5
, pp. 1055-1064
-
-
Hamid, T.1
Malik, M.T.2
Millar, R.P.3
Kakar, S.S.4
-
71
-
-
21644450905
-
Akting and cycling: A tale of the pituitary
-
Grossman AB, Korbonits M. Akting and cycling: a tale of the pituitary. Horm. Res. 62(Suppl. 3), 117-123 (2004).
-
(2004)
Horm. Res.
, vol.62
, Issue.SUPPL. 3
, pp. 117-123
-
-
Grossman, A.B.1
Korbonits, M.2
-
72
-
-
46349095103
-
Activation of phosphatidylinositol 3-kinase signaling promotes aberrant pituitary growth in a mouse model of thyroid-stimulating hormone-secreting pituitary tumors
-
DOI 10.1210/en.2007-1696
-
Lu C, Willingham MC, Furuya F, Cheng SY. Activation of phosphatidylinositol 3-kinase signalling promotes aberrant pituitary growth in a mouse model of thyroid-stimulating hormone-secreting pituitary tumours. Endocrinology 149(7), 3339-3345 (2008). (Pubitemid 351919619)
-
(2008)
Endocrinology
, vol.149
, Issue.7
, pp. 3339-3345
-
-
Lu, C.1
Willingham, M.C.2
Furuya, F.3
Cheng, S.-Y.4
-
73
-
-
51849098272
-
Drug discovery approaches targeting the PI3K/AKT pathway in cancer
-
Summarizes current preclinical knowledge of modulators of the PI3K/Akt
-
Garcia-Echeverria C, Sellers WR. Drug discovery approaches targeting the PI3K/AKT pathway in cancer. Oncogene 27(41), 5511-5526 (2008). • Summarizes current preclinical knowledge of modulators of the PI3K/Akt.
-
(2008)
Oncogene
, vol.27
, Issue.41
, pp. 5511-5526
-
-
Garcia-Echeverria, C.1
Sellers, W.R.2
-
74
-
-
65549088020
-
Frequent mutations and amplifications of the PIK3CA gene in pituitary tumours
-
Lin Y, Jiang X, Shen Y et al. Frequent mutations and amplifications of the PIK3CA gene in pituitary tumours. Endocr. Relat. Cancer 16(1), 301-310 (2009).
-
(2009)
Endocr. Relat. Cancer
, vol.16
, Issue.1
, pp. 301-310
-
-
Lin, Y.1
Jiang, X.2
Shen, Y.3
-
75
-
-
0035754080
-
To cycle or not to cycle: A critical decision in cancer
-
Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 1(3), 222-231 (2001). (Pubitemid 33741897)
-
(2001)
Nature Reviews Cancer
, vol.1
, Issue.3
, pp. 222-231
-
-
Malumbres, M.1
Barbacid, M.2
-
76
-
-
36749011176
-
Signaling and epigenetic regulation of pituitary development
-
DOI 10.1016/j.ceb.2007.09.011, PII S0955067407001330, Cell Differentiation / Cell Division, Growth and Death
-
Zhu X, Wang J, Ju BG, Rosenfeld MG. Signalling and epigenetic regulation of pituitary development. Curr. Opin. Cell Biol. 19(6), 605-611 (2007). (Pubitemid 350216419)
-
(2007)
Current Opinion in Cell Biology
, vol.19
, Issue.6
, pp. 605-611
-
-
Zhu, X.1
Wang, J.2
Ju, B.-G.3
Rosenfeld, M.G.4
-
77
-
-
60749136421
-
Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway
-
Implicates the noncanonical Wnt signaling pathway in proliferation and survival of the pituitary adenomas
-
Miyakoshi T, Takei M, Kajiya H et al. Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway. Endocr. Pathol. 19(4), 261-273 (2008). • Implicates the noncanonical Wnt signaling pathway in proliferation and survival of the pituitary adenomas.
-
(2008)
Endocr. Pathol.
, vol.19
, Issue.4
, pp. 261-273
-
-
Miyakoshi, T.1
Takei, M.2
Kajiya, H.3
-
78
-
-
40849096171
-
Wnt pathway inhibitors are strongly down-regulated in pituitary tumours
-
Elston MS, Gill AJ, Conaglen JV et al. Wnt pathway inhibitors are strongly down-regulated in pituitary tumours. Endocrinology 149(3), 1235-1242 (2008).
-
(2008)
Endocrinology
, vol.149
, Issue.3
, pp. 1235-1242
-
-
Elston, M.S.1
Gill, A.J.2
Conaglen, J.V.3
-
79
-
-
70449701998
-
Activation of the Wnt 5A, β-catenin, TCF-4, cyclin D1 and Ecadherin in null cell pituitary adenomas
-
Presented at
-
Kremenevskaya N, Khattak M, Buchfelder M. Activation of the Wnt 5A, β-catenin, TCF-4, cyclin D1 and Ecadherin in null cell pituitary adenomas. Presented at: The 89th Annual Meeting of The Endocrine Society. Toronto, ON, Canada, 2-5 June 2007.
-
The 89th Annual Meeting of the Endocrine Society. Toronto, ON, Canada, 2-5 June 2007
-
-
Kremenevskaya, N.1
Khattak, M.2
Buchfelder, M.3
-
80
-
-
33751073938
-
Cross-talk of WNT and FGF signaling pathways at GSK3β to regulate β-catenin and SNAIL signaling cascades
-
Katoh M. Cross-talk of WNT and FGF signalling pathways at GSK3β to regulate β-catenin and SNAIL signalling cascades. Cancer Biol. Ther. 5(9), 1059-1064 (2006). (Pubitemid 44772212)
-
(2006)
Cancer Biology and Therapy
, vol.5
, Issue.9
, pp. 1059-1064
-
-
Katoh, M.1
Katoh, M.2
-
81
-
-
34247192417
-
The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth
-
DOI 10.1038/sj.emboj.7601636, PII 7601636
-
Canibano C, Rodriguez NL, Saez C et al. The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/ p53 pathway, preventing tumor growth. EMBO J. 26(8), 2015-2028 (2007). (Pubitemid 46625783)
-
(2007)
EMBO Journal
, vol.26
, Issue.8
, pp. 2015-2028
-
-
Canibano, C.1
Rodriguez, N.L.2
Saez, C.3
Tovar, S.4
Garcia-Lavandeira, M.5
Borrello, M.G.6
Vidal, A.7
Costantini, F.8
Japon, M.9
Dieguez, C.10
Alvarez, C.V.11
-
82
-
-
0034455668
-
Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased α-subunit secretion
-
DOI 10.1210/jc.85.7.2537
-
Skelly RH, Korbonits M, Grossman A et al. Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased α-subunit secretion. J. Clin. Endocrinol. Metab. 85(7), 2537-2542 (2000). (Pubitemid 32269212)
-
(2000)
Journal of Clinical Endocrinology and Metabolism
, vol.85
, Issue.7
, pp. 2537-2542
-
-
Skelly, R.H.1
Korbonits, M.2
Grossman, A.3
Besser, G.M.4
Monson, J.P.5
Geddes, J.F.6
Burrin, J.M.7
-
83
-
-
27544470656
-
Mammalian cyclin-dependent kinases
-
Malumbres M, Barbacid M. Mammalian cyclin-dependent kinases. Trends Biochem. Sci. 30(11), 630-641 (2005).
-
(2005)
Trends Biochem. Sci.
, vol.30
, Issue.11
, pp. 630-641
-
-
Malumbres, M.1
Barbacid, M.2
-
84
-
-
34250372017
-
Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues
-
DOI 10.1158/0008-5472.CAN-06-3437
-
Ramsey MR, Krishnamurthy J, Pei XH et al. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumours and tissues. Cancer Res. 67(10), 4732-4741 (2007). (Pubitemid 46910180)
-
(2007)
Cancer Research
, vol.67
, Issue.10
, pp. 4732-4741
-
-
Ramsey, M.R.1
Krishnamurthy, J.2
Pei, X.-H.3
Torrice, C.4
Lin, W.5
Carrasco, D.R.6
Ligon, K.L.7
Xiong, Y.8
Sharpless, N.E.9
-
85
-
-
18244395828
-
INK4a/RB1 pathway is frequently deregulated in human pituitary adenomas
-
Ogino A, Yoshino A, Katayama Y et al. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas. J. Neuropathol. Exp. Neurol. 64(5), 398-403 (2005). (Pubitemid 40629130)
-
(2005)
Journal of Neuropathology and Experimental Neurology
, vol.64
, Issue.5
, pp. 398-403
-
-
Ogino, A.1
Yoshino, A.2
Katayama, Y.3
Watanabe, T.4
Ota, T.5
Komine, C.6
Yokoyama, T.7
Fukushima, T.8
-
86
-
-
24644470534
-
Expression of retinoblastoma protein in human growth hormone-secreting pituitary adenomas
-
Donangelo I, Marcos HP, Araujo PB et al. Expression of retinoblastoma protein in human growth hormone-secreting pituitary adenomas. Endocr. Pathol. 16(1), 53-62 (2005). (Pubitemid 41278315)
-
(2005)
Endocrine Pathology
, vol.16
, Issue.1
, pp. 53-62
-
-
Donangelo, I.1
Marcos, H.P.2
Araujo, P.B.3
Marcondes, J.4
Niemeyer Filho, P.5
Gadelha, M.6
Chimelli, L.7
-
87
-
-
43749120732
-
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
-
DOI 10.2174/156800908784293659
-
Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF. The PTEN/PI3K/ AKT signalling pathway in cancer, therapeutic implications. Curr. Cancer Drug Targets 8(3), 187-198 (2008). (Pubitemid 351688437)
-
(2008)
Current Cancer Drug Targets
, vol.8
, Issue.3
, pp. 187-198
-
-
Carnero, A.1
Blanco-Aparicio, C.2
Renner, O.3
Link, W.4
Leal, J.F.M.5
-
88
-
-
37549036250
-
CDK inhibitors in cancer therapy: What is next?
-
Malumbres M, Pevarello P, Barbacid M, Bischoff JR. CDK inhibitors in cancer therapy: what is next? Trends Pharmacol. Sci. 29(1), 16-21 (2008).
-
(2008)
Trends Pharmacol. Sci.
, vol.29
, Issue.1
, pp. 16-21
-
-
Malumbres, M.1
Pevarello, P.2
Barbacid, M.3
Bischoff, J.R.4
-
89
-
-
34447094967
-
A census of mitotic cancer genes: New insights into tumor cell biology and cancer therapy
-
DOI 10.1093/carcin/bgm019
-
Perez de Castro I, de Carcer G, Malumbres M. A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy. Carcinogenesis 28(5), 899-912 (2007). (Pubitemid 47072171)
-
(2007)
Carcinogenesis
, vol.28
, Issue.5
, pp. 899-912
-
-
Perez De Castro, I.1
De Carcer, G.2
Malumbres, M.3
-
90
-
-
18144424779
-
kip1 in tumor development: A preclinical model to evaluate cell cycle inhibitors with therapeutic activity
-
DOI 10.1158/0008-5472.CAN-04-4195
-
Sotillo R, Renner O, Dubus P et al. Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity. Cancer Res. 65(9), 3846-3852 (2005). (Pubitemid 40616365)
-
(2005)
Cancer Research
, vol.65
, Issue.9
, pp. 3846-3852
-
-
Sotillo, R.1
Renner, O.2
Dubus, P.3
Ruiz-Cabello, J.4
Martin-Caballero, J.5
Barbacid, M.6
Carnero, A.7
Malumbres, M.8
-
92
-
-
33744486595
-
Pituitary adenoma predisposition caused by germline mutations in the AIP gene
-
DOI 10.1126/science.1126100
-
Vierimaa O, Georgitsi M, Lehtonen R et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312(5777), 1228-1230 (2006). (Pubitemid 43801151)
-
(2006)
Science
, vol.312
, Issue.5777
, pp. 1228-1230
-
-
Vierimaa, O.1
Georgitsi, M.2
Lehtonen, R.3
Vahteristo, P.4
Kokko, A.5
Raitila, A.6
Tuppurainen, K.7
Ebeling, T.M.L.8
Salmela, P.I.9
Paschke, R.10
Gundogdu, S.11
De Menis, E.12
Makinen, M.J.13
Launonen, V.14
Karhu, A.15
Aaltonen, L.A.16
-
93
-
-
34249844835
-
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: Analysis in 73 families
-
Daly AF, Vanbellinghen JF, Khoo SK et al. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J. Clin. Endocrinol. Metab. 92(5), 1891-1896 (2007).
-
(2007)
J. Clin. Endocrinol. Metab.
, vol.92
, Issue.5
, pp. 1891-1896
-
-
Daly, A.F.1
Vanbellinghen, J.F.2
Khoo, S.K.3
-
94
-
-
34249862215
-
Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma
-
Toledo RA, Lourenco DM, Jr., Liberman B et al. Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma. J. Clin. Endocrinol. Metab. 92(5), 1934-1937 (2007).
-
(2007)
J. Clin. Endocrinol. Metab.
, vol.92
, Issue.5
, pp. 1934-1937
-
-
Toledo, R.A.1
Lourenco Jr., D.M.2
Liberman, B.3
-
95
-
-
51649091623
-
Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas
-
Georgitsi M, De Menis E, Cannavo S et al. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas. Clin. Endocrinol. (Oxf.) 69(4), 621-627 (2008).
-
(2008)
Clin. Endocrinol. (Oxf.)
, vol.69
, Issue.4
, pp. 621-627
-
-
Georgitsi, M.1
De Menis, E.2
Cannavo, S.3
-
96
-
-
0031736203
-
Somatic mutations of the mitochondrial genome in human colorectal tumours
-
DOI 10.1038/3108
-
Polyak K, Li Y, Zhu H et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat. Genet. 20(3), 291-293 (1998). (Pubitemid 28507677)
-
(1998)
Nature Genetics
, vol.20
, Issue.3
, pp. 291-293
-
-
Polyak, K.1
Li, Y.2
Zhu, H.3
Lengauer, C.4
Willson, J.K.V.5
Markowitz, S.D.6
Trush, M.A.7
Kinzler, K.W.8
Vogelstein, B.9
-
97
-
-
33847298866
-
Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas
-
DOI 10.1186/bcr1637
-
Chanock SJ, Burdett L, Yeager M et al. Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas. Breast Cancer Res. 9(1), R5 (2007). (Pubitemid 350215156)
-
(2007)
Breast Cancer Research
, vol.9
, Issue.1
-
-
Chanock, S.J.1
Burdett, L.2
Yeager, M.3
Llaca, V.4
Langerod, A.5
Presswalla, S.6
Kaaresen, R.7
Strausberg, R.L.8
Gerhard, D.S.9
Kristensen, V.10
Perou, C.M.11
Borresen-Dale, A.-L.12
-
98
-
-
0037143442
-
Regulation of human separase by securin binding and autocleavage
-
DOI 10.1016/S0960-9822(02)01073-4, PII S0960982202010734
-
Waizenegger I, Gimenez-Abian JF, Wernic D, Peters JM. Regulation of human separase by securin binding and autocleavage. Curr. Biol. 12(16), 1368-1378 (2002). (Pubitemid 34915538)
-
(2002)
Current Biology
, vol.12
, Issue.16
, pp. 1368-1378
-
-
Waizenegger, I.C.1
Gimenez-Abian, J.F.2
Wernic, D.3
Peters, J.-M.4
-
99
-
-
33646448886
-
Expression of p53, Ki-67 and c-erb B2 in growth hormone-and/or prolactin-secreting pituitary adenomas
-
Botelho CH, Magalhães AV, Mello PA, Schmitt FC, Casulari LA. Expression of p53, Ki-67 and c-erb B2 in growth hormone-and/or prolactin-secreting pituitary adenomas. Arq. Neuropsiquiatr. 64(1), 60-66 (2006).
-
(2006)
Arq. Neuropsiquiatr.
, vol.64
, Issue.1
, pp. 60-66
-
-
Botelho, C.H.1
Magalhães, A.V.2
Mello, P.A.3
Schmitt, F.C.4
Casulari, L.A.5
-
100
-
-
33750361636
-
Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans
-
DOI 10.1073/pnas.0603877103
-
Pellegata NS, Quintanilla-Martinez L, Siggelkow H et al. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc. Natl Acad. Sci. USA 103(42), 15558-15563 (2006). (Pubitemid 44625631)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.42
, pp. 15558-15563
-
-
Pellegata, N.S.1
Quintanilla-Martinez, L.2
Siggelkow, H.3
Samson, E.4
Bink, K.5
Hofler, H.6
Fend, F.7
Graw, J.8
Atkinson, M.J.9
-
101
-
-
0035030696
-
Combined pituitary hormone deficiency caused by compound heterozygosity for two novel mutations in the POU domain of the PIT1/POU1F1 gene
-
DOI 10.1210/jc.86.4.1545
-
Hendriks-Stegeman BI, Augustijn KD, Bakker B, Holthuizen P, van der Vliet PC, Jansen M. Combined pituitary hormone deficiency caused by compound heterozygosity for two novel mutations in the POU domain of the Pit-1/POU1F1 gene. J. Clin. Endocrinol. Metab. 86(4), 1545-1550 (2001). (Pubitemid 32374901)
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.4
, pp. 1545-1550
-
-
Augustijn, K.D.1
Bakker, B.2
Holthuizen, P.3
Van Der Vliet, P.C.4
Jansen, M.5
-
102
-
-
0036118561
-
Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4
-
DOI 10.1128/MCB.22.7.2242-2254.2002
-
Leng X, Noble M, Adams PD, Qin J, Harper JW. Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4. Mol. Cell Biol. 22(7), 2242-2254 (2002). (Pubitemid 34224630)
-
(2002)
Molecular and Cellular Biology
, vol.22
, Issue.7
, pp. 2242-2254
-
-
Leng, X.1
Noble, M.2
Adams, P.D.3
Qin, J.4
Harper, J.W.5
|